Defense Health Board; Notice of Federal Advisory Committee Meeting, 29853-29854 [2016-11342]

Download as PDF mstockstill on DSK3G9T082PROD with NOTICES Federal Register / Vol. 81, No. 93 / Friday, May 13, 2016 / Notices matters. The Board shall be composed of no more than 20 members, all of whom are distinguished members of the science and technology communities, Federally Funded Research and Development Centers, National Laboratories, industry, and academia (universities and colleges). Members who are not full-time or permanent parttime Federal officers or employees are appointed as experts or consultants pursuant to 5 U.S.C. 3109 to serve as special government employee members. Members who are full-time or permanent part-time Federal officers or employees are appointed pursuant to 41 CFR 102–3.130(a) to serve as regular government employee members. All members are appointed to provide advice on behalf of the Government on the basis of their best judgment without representing any particular point of view and in a manner that is free from conflict of interest. Except for reimbursement of official Board-related travel and per diem, members serve without compensation. The DoD, as necessary and consistent with the Board’s mission and DoD policies and procedures, may establish subcommittees, task forces, or working groups to support the Board, and all subcommittees must operate under the provisions of FACA and the Government in the Sunshine Act. Subcommittees will not work independently of the Board and must report all recommendations and advice solely to the Board for full deliberation and discussion. Subcommittees, task forces, or working groups have no authority to make decisions and recommendations, verbally or in writing, on behalf of the Board. No subcommittee or any of its members can update or report, verbally or in writing, directly to the DoD or any Federal officers or employees. The Board’s DFO, pursuant to DoD policy, must be a fulltime or permanent part-time DoD employee, and must be in attendance for the duration of each and every Board/ subcommittee meeting. The public or interested organizations may submit written statements to the Board membership about the Board’s mission and functions. Such statements may be submitted at any time or in response to the stated agenda of planned Board. All written statements must be submitted to the Board’s DFO who will ensure the written statements are provided to the membership for their consideration. VerDate Sep<11>2014 18:05 May 12, 2016 Jkt 238001 Dated: May 10, 2016. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2016–11308 Filed 5–12–16; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Defense Health Board; Notice of Federal Advisory Committee Meeting Department of Defense (DoD). Notice of Federal Advisory Committee meeting. AGENCY: ACTION: The Department of Defense is publishing this notice to announce that the following Federal Advisory Committee meeting of the Defense Health Board will take place. DATES: SUMMARY: Thursday, June 2, 2016 9:00 a.m.–10:15 a.m. (Closed Session) 10:15 a.m.–11:45 a.m. (Open Session) 11:45 a.m.–12:45 p.m. (Administrative Session) 12:45 p.m.–5:00 p.m. (Open Session) ADDRESSES: Defense Health Headquarters (DHHQ), Pavilion Salons B–C, 7700 Arlington Blvd., Falls Church, Virginia 22042 (escort required; see guidance in SUPPLEMENTARY INFORMATION, ‘‘Public’s Accessibility to the Meeting’’). FOR FURTHER INFORMATION CONTACT: The Executive Director of the Defense Health Board is Ms. Christine Bader, 7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042, (703) 681–6653, Fax: (703) 681–9539, christine.e.bader.civ@mail.mil. For meeting information, please contact Ms. Kendal Brown, 7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042, kendal.l.brown2.ctr@ mail.mil, (703) 681–6670, Fax: (703) 681–9539. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150. Additional information, including the agenda and electronic registration, is available at the DHB Web site, https:// www.health.mil/About-MHS/OtherMHS-Organizations/Defense-HealthBoard/Meetings. Purpose of the Meeting The purpose of the meeting is to provide progress updates on specific PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 29853 taskings before the DHB. In addition, the DHB will receive information briefings on current issues or lessons learned related to military medicine, health policy, health research, disease/injury prevention, health promotion, and healthcare delivery. Agenda Pursuant to 5 U.S.C. 552b and 41 CFR 102–3.155, in the interest of national security, the DoD has determined that the first presentation in the morning of June 2, 2016 will be closed to the public. The topic is a presentation on the mission and functions of the National Center for Medical Intelligence. The Assistant Secretary of Defense (Health Affairs), in consultation with the Office of the DoD General Counsel, has determined in writing that the public interest requires that the first presentation in the morning session on June 2, 2016 be closed to the public because it will concern matters listed in section 552b(c)(1) of title 5, United States Code. The classified materials are so inextricably intertwined with the unclassified material that they cannot be reasonably segregated into separate discussions without disclosing SECRET material. Specifically, the information presented meets criteria established by an Executive Order to be kept secret in the interest of national defense and foreign policy. Pursuant to 5 U.S.C. 552b and 41 CFR 102–3.140 through 102–3.165 and subject to availability of space, the DHB meeting is open to the public from 10:15 a.m. to 11:45 a.m. on June 2, 2016, and from 12:45 p.m. to 5:00 p.m. The DHB will receive a progress update from the Health Care Delivery Subcommittee on the pediatric clinical preventive services review and an update from the Public Health Subcommittee on their review of improving Defense Health Program medical research processes. In addition, the DHB anticipates receiving information briefings on Defense Advanced Research Projects Agency medical research, the Army Study to Assess Risk and Resilience in Servicemembers (STARRS), the Infectious Disease Clinical Research Program, and Advances in the Use of Whole Blood for Combat Trauma Resuscitation. Any changes to the agenda can be found at the link provided in this SUPPLEMENTARY INFORMATION section. Public’s Accessibility to the Meeting Pursuant to 5 U.S.C. 552b, and 41 CFR 102–3.140 through 102–3.165 and subject to availability of space, this meeting is open to the public. Seating is limited and is on a first-come basis. All E:\FR\FM\13MYN1.SGM 13MYN1 29854 Federal Register / Vol. 81, No. 93 / Friday, May 13, 2016 / Notices members of the public who wish to attend the public meeting must contact Ms. Kendal Brown at the number listed in the section FOR FURTHER INFORMATION CONTACT no later than 12:00 p.m. on Wednesday, May 25, 2016 to register. Additional details will be provided to all registrants. Special Accommodations Individuals requiring special accommodations to access the public meeting should contact Ms. Kendal Brown at least five (5) business days prior to the meeting so that appropriate arrangements can be made. mstockstill on DSK3G9T082PROD with NOTICES Written Statements Any member of the public wishing to provide comments to the DHB may do so in accordance with section 10(a)(3) of the Federal Advisory Committee Act, 41 CFR 102–3.105(j) and 102–3.140, and the procedures described in this notice. Individuals desiring to provide comments to the DHB may do so by submitting a written statement to the DHB Designated Federal Officer (DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should not be longer than two type-written pages and address the following details: The issue, discussion, and a recommended course of action. Supporting documentation may also be included, as needed, to establish the appropriate historical context and to provide any necessary background information. If the written statement is not received at least five (5) business days prior to the meeting, the DFO may choose to postpone consideration of the statement until the next open meeting. The DFO will review all timely submissions with the DHB President and ensure they are provided to members of the DHB before the meeting that is subject to this notice. After reviewing the written comments, the President and the DFO may choose to invite the submitter to orally present their issue during an open portion of this meeting or at a future meeting. The DFO, in consultation with the DHB President, may allot time for members of the public to present their issues for review and discussion by the Defense Health Board. Dated: May 10, 2016. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2016–11342 Filed 5–12–16; 8:45 am] BILLING CODE 5001–06–P VerDate Sep<11>2014 18:05 May 12, 2016 Jkt 238001 DEPARTMENT OF EDUCATION [Docket No. ED–2016–ICCD–0025] Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Formula Grant EASIE (Electronic Application System for Indian Education) Department of Education (ED), Office of Elementary and Secondary Education (OESE). ACTION: Notice. AGENCY: In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 3501 et seq.), ED is proposing an extension of an existing information collection. DATES: Interested persons are invited to submit comments on or before June 13, 2016. ADDRESSES: To access and review all the documents related to the information collection listed in this notice, please use https://www.regulations.gov by searching the Docket ID number ED– 2016–ICCD–0025. Comments submitted in response to this notice should be submitted electronically through the Federal eRulemaking Portal at https:// www.regulations.gov by selecting the Docket ID number or via postal mail, commercial delivery, or hand delivery. Please note that comments submitted by fax or email and those submitted after the comment period will not be accepted. Written requests for information or comments submitted by postal mail or delivery should be addressed to the Director of the Information Collection Clearance Division, U.S. Department of Education, 400 Maryland Avenue SW., LBJ, Room 2E–115 Washington, DC 20202–4537. FOR FURTHER INFORMATION CONTACT: For specific questions related to collection activities, please contact Kimberly Smith, 202–453–6469. SUPPLEMENTARY INFORMATION: The Department of Education (ED), in accordance with the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)), provides the general public and Federal agencies with an opportunity to comment on proposed, revised, and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the public’s reporting burden. It also helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. ED is soliciting comments on the proposed SUMMARY: PO 00000 Frm 00023 Fmt 4703 Sfmt 9990 information collection request (ICR) that is described below. The Department of Education is especially interested in public comment addressing the following issues: (1) Is this collection necessary to the proper functions of the Department; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the respondents, including through the use of information technology. Please note that written comments received in response to this notice will be considered public records. Title of Collection: Formula Grant EASIE (Electronic Application System for Indian Education). OMB Control Number: 1810–0021. Type of Review: An extension of an existing information collection. Respondents/Affected Public: State, Local, and Tribal Governments. Total Estimated Number of Annual Responses: 11,300. Total Estimated Number of Annual Burden Hours: 9,103. Abstract: The Indian Education Formula Grant (CFDA 84.060A) requires the annual submission of the application from the local educational agency and/or tribe. The amount of each applicant’s award is determined by formula, based upon the reported number of American Indian/Alaska Native students identified in the application, the state per pupil expenditure, and the total appropriation available. Applicants provide the data required for funding electronically, and the Office of Indian Education (OIE) is able to apply electronic tools to facilitate the review and analysis leading to grant awards. The system has been named Formula Grant Electronic Application System for Indian Education (EASIE), and is located in the EDFacts System (ESS) Web site. Dated: May 10, 2016. Tomakie Washington, Acting Director, Information Collection Clearance Division, Office of the Chief Privacy Officer, Office of Management. [FR Doc. 2016–11303 Filed 5–12–16; 8:45 am] BILLING CODE 4000–01–P E:\FR\FM\13MYN1.SGM 13MYN1

Agencies

[Federal Register Volume 81, Number 93 (Friday, May 13, 2016)]
[Notices]
[Pages 29853-29854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11342]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board; Notice of Federal Advisory Committee 
Meeting

AGENCY: Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Defense Health Board will take place.

DATES: 

Thursday, June 2, 2016

9:00 a.m.-10:15 a.m. (Closed Session)
10:15 a.m.-11:45 a.m. (Open Session)
11:45 a.m.-12:45 p.m. (Administrative Session)
12:45 p.m.-5:00 p.m. (Open Session)

ADDRESSES: Defense Health Headquarters (DHHQ), Pavilion Salons B-C, 
7700 Arlington Blvd., Falls Church, Virginia 22042 (escort required; 
see guidance in SUPPLEMENTARY INFORMATION, ``Public's Accessibility to 
the Meeting'').

FOR FURTHER INFORMATION CONTACT: The Executive Director of the Defense 
Health Board is Ms. Christine Bader, 7700 Arlington Boulevard, Suite 
5101, Falls Church, Virginia 22042, (703) 681-6653, Fax: (703) 681-
9539, christine.e.bader.civ@mail.mil. For meeting information, please 
contact Ms. Kendal Brown, 7700 Arlington Boulevard, Suite 5101, Falls 
Church, Virginia 22042, kendal.l.brown2.ctr@mail.mil, (703) 681-6670, 
Fax: (703) 681-9539.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., 
Appendix, as amended), the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended), and 41 CFR 102-3.150.
    Additional information, including the agenda and electronic 
registration, is available at the DHB Web site, https://www.health.mil/About-MHS/Other-MHS-Organizations/Defense-Health-Board/Meetings.

Purpose of the Meeting

    The purpose of the meeting is to provide progress updates on 
specific taskings before the DHB. In addition, the DHB will receive 
information briefings on current issues or lessons learned related to 
military medicine, health policy, health research, disease/injury 
prevention, health promotion, and healthcare delivery.

Agenda

    Pursuant to 5 U.S.C. 552b and 41 CFR 102-3.155, in the interest of 
national security, the DoD has determined that the first presentation 
in the morning of June 2, 2016 will be closed to the public. The topic 
is a presentation on the mission and functions of the National Center 
for Medical Intelligence. The Assistant Secretary of Defense (Health 
Affairs), in consultation with the Office of the DoD General Counsel, 
has determined in writing that the public interest requires that the 
first presentation in the morning session on June 2, 2016 be closed to 
the public because it will concern matters listed in section 552b(c)(1) 
of title 5, United States Code. The classified materials are so 
inextricably intertwined with the unclassified material that they 
cannot be reasonably segregated into separate discussions without 
disclosing SECRET material. Specifically, the information presented 
meets criteria established by an Executive Order to be kept secret in 
the interest of national defense and foreign policy.
    Pursuant to 5 U.S.C. 552b and 41 CFR 102-3.140 through 102-3.165 
and subject to availability of space, the DHB meeting is open to the 
public from 10:15 a.m. to 11:45 a.m. on June 2, 2016, and from 12:45 
p.m. to 5:00 p.m. The DHB will receive a progress update from the 
Health Care Delivery Subcommittee on the pediatric clinical preventive 
services review and an update from the Public Health Subcommittee on 
their review of improving Defense Health Program medical research 
processes. In addition, the DHB anticipates receiving information 
briefings on Defense Advanced Research Projects Agency medical 
research, the Army Study to Assess Risk and Resilience in 
Servicemembers (STARRS), the Infectious Disease Clinical Research 
Program, and Advances in the Use of Whole Blood for Combat Trauma 
Resuscitation. Any changes to the agenda can be found at the link 
provided in this SUPPLEMENTARY INFORMATION section.

Public's Accessibility to the Meeting

    Pursuant to 5 U.S.C. 552b, and 41 CFR 102-3.140 through 102-3.165 
and subject to availability of space, this meeting is open to the 
public. Seating is limited and is on a first-come basis. All

[[Page 29854]]

members of the public who wish to attend the public meeting must 
contact Ms. Kendal Brown at the number listed in the section FOR 
FURTHER INFORMATION CONTACT no later than 12:00 p.m. on Wednesday, May 
25, 2016 to register. Additional details will be provided to all 
registrants.

Special Accommodations

    Individuals requiring special accommodations to access the public 
meeting should contact Ms. Kendal Brown at least five (5) business days 
prior to the meeting so that appropriate arrangements can be made.

Written Statements

    Any member of the public wishing to provide comments to the DHB may 
do so in accordance with section 10(a)(3) of the Federal Advisory 
Committee Act, 41 CFR 102-3.105(j) and 102-3.140, and the procedures 
described in this notice.
    Individuals desiring to provide comments to the DHB may do so by 
submitting a written statement to the DHB Designated Federal Officer 
(DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should 
not be longer than two type-written pages and address the following 
details: The issue, discussion, and a recommended course of action. 
Supporting documentation may also be included, as needed, to establish 
the appropriate historical context and to provide any necessary 
background information.
    If the written statement is not received at least five (5) business 
days prior to the meeting, the DFO may choose to postpone consideration 
of the statement until the next open meeting.
    The DFO will review all timely submissions with the DHB President 
and ensure they are provided to members of the DHB before the meeting 
that is subject to this notice. After reviewing the written comments, 
the President and the DFO may choose to invite the submitter to orally 
present their issue during an open portion of this meeting or at a 
future meeting. The DFO, in consultation with the DHB President, may 
allot time for members of the public to present their issues for review 
and discussion by the Defense Health Board.

    Dated: May 10, 2016.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2016-11342 Filed 5-12-16; 8:45 am]
BILLING CODE 5001-06-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.